EUVIMEDOpdag EUVIMED
Fallbericht

Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis

Masahiro Biyajima iD, Yusuke Nakamura, Toshihiro Nagaoka, Ko-Ichi Tazawa

Journal of Clinical Apheresis · 2026

DOI: 10.1002/jca.70185 ↗

At a glance

Fallbericht in Journal of Clinical Apheresis, 2026. Written by Masahiro Biyajima and 3 co-authors. Institution: Department of Neurology, Japanese Red Cross Nagano Hospital, Nagano, Japan. Major MEDLINE topics: Long QT Syndrome, Torsades de Pointes, Myasthenia Gravis, Blood Component Removal. 6 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Citrate anticoagulation during therapeutic plasma exchange (TPE) chelates divalent cations and can precipitate torsades de pointes (TdP) in patients with pre‐existing repolarization vulnerability. We report a 44‐year‐old woman with genetically determined long QT syndrome Type 2 (LQT2) presenting in myasthenic crisis due to anti‐MuSK‐positive myasthenia gravis. TPE was initiated urgently before confirmatory antibody results were available, as alternative rapid immunomodulatory options were not immediately accessible. Despite prophylactic electrolyte supplementation, the corrected QT interval (QTc) progressively prolonged, rising from a baseline of 493 to 509 ms—exceeding the 500 ms high‐risk threshold—immediately before TdP onset during the second TPE. TPE was discontinued and replaced with double‐filtration plasmapheresis (DFPP) using albumin‐based replacement, which reduces citrate exposure by retaining the patient's own albumin. Five subsequent DFPP sessions were completed without arrhythmia recurrence. This case highlights the apheresis‐related arrhythmia risk in LQT2 and the mechanistic rationale for DFPP as a safer alternative.

Subjects

MeSH terms (MEDLINE)

Long QT SyndromeTorsades de PointesMyasthenia GravisBlood Component RemovalCitric AcidHumansFemaleAdultPlasmapheresisPlasma ExchangeArrhythmias, Cardiac

Author keywords

citrate anticoagulationdouble‐filtration plasmapheresislong QT syndromemyasthenia gravistherapeutic plasma exchangetorsades de pointes

Substances

Citric Acid

Authors and institutions

  • Department of Neurology, Japanese Red Cross Nagano Hospital, Nagano, Japan.
  • Department of Nephrology, Japanese Red Cross Nagano Hospital, Nagano, Japan.

ORCID profiles: Masahiro Biyajima

Cite

APA

Biyajima, M., Nakamura, Y., Nagaoka, T., & Tazawa, K. I. (2026). Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70185

Vancouver

Biyajima M, Nakamura Y, Nagaoka T, Tazawa KI. Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis. Journal of Clinical Apheresis. 2026. doi:10.1002/jca.70185

BibTeX
@article{Biyajima2026,
  author = {Biyajima, Masahiro and Nakamura, Yusuke and Nagaoka, Toshihiro and Tazawa, Ko-Ichi},
  title = {Apheresis‐Triggered Torsades De Pointes in Congenital Long QT Syndrome Type 2: Citrate‐Related Arrhythmia Risk and Safe Modality Switching During Myasthenic Crisis},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  doi = {10.1002/jca.70185}
}
Start for free →